Bruker Daltonics Launches New apex®-ultra FTMS at Pittcon 2007

apex®-ultra Sets New Standard for High-Performance FTMS in Top-Down Proteomics and Complex Mixtures Analysis

CHICAGO, Illinois --Feb. 25th 2007 —

At Pittcon 2007, Bruker Daltonics today announces its new apex®-ultra FTMS mass spectrometer, featuring wider mass range transmission, highest resolving power, even better mass accuracy and faster data acquisition. Bruker’s unique refrigerated FTMS magnet technology is available as an option at 7, 9.4, 12 (...)

Bruker Daltonics Expands its MALDI Molecular Imager™ Integrated Systems Solution at Pittcon 2007

CHICAGO, Illinois --Feb. 25th 2007 — At Pittcon 2007, Bruker Daltonics has added high performance automated tissue sample preparation and its unique ClassImaging™ algorithm to its MALDI Molecular Imager™ systems solution. MALDI molecular imaging has emerged as a powerful research tool for biomarker detection, tissue classification and pathology research, as well as for imaging the distributions of drugs and metabolites in drug development. Bruker’s (...)

Bruker Daltonics Launches Latest Compass™ 1.2 Software with Support for Leading Liquid Chromatography Systems and API-Sources

CHICAGO, Illinois -- February 25, 2007 — At Pittcon 2007, Bruker Daltonics announces the release of Compass™ 1.2 software for its HCT™ high-capacity ion traps and micrOTOF™ ESI-(Q-q)-TOF mass spectrometers, providing significant new functionality for customers.

The new Compass version 1.2 offers a variety of new features and workflows for proteomics and small molecule applications, including Electron Transfer Dissociation (ETD) with the HCTultra (...)

Bruker Daltonics Introduces Unique flexImaging(TM) 2.0 Software for MALDI Mass & Class Imaging in Biomarker Discovery and Drug Imaging

SANIBEL ISLAND, Fla., Jan 20, 2007 (BUSINESS WIRE) --

At the 18th ASMS Sanibel Conference on Imaging Mass Spectrometry, Bruker Daltonics today announces the release of its new flexImaging 2.0 software solution for acquisition and evaluation of MALDI-TOF and TOF/TOF imaging data.

MALDI imaging of tissue samples with Bruker's novel flexImaging 2.0 allows color-coded visualization of the distribution of biomarkers or absorbed drugs and their major (...)

Bruker BioSciences Announces Filing of S-3 Registration Statement

BILLERICA, Mass., Dec 15, 2006 (BUSINESS WIRE) --

Bruker BioSciences Corporation (NASDAQ: BRKR) announced today that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission relating to a proposed offering of an aggregate of 10,400,000 shares of its common stock. Of these 10,400,000 shares, the Company is offering 2,200,000 shares and four of its major Laukien shareholders, specifically Isolde Laukien-Kleiner, Joerg (...)